Information:
Fel:
ID
19259
Beskrivning
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).
Nyckelord
Versioner (1)
- 2016-12-15 2016-12-15 -
Uppladdad den
15 december 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC-ND 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
WTZ-GIST-09-01 (Imatinib + LBH589) Dosage administration record 2009-011417-24 DRKS00000657
WTZ-GIST-09-01 (Imatinib + LBH589) Dosage administration record 2009-011417-24
Similar models
WTZ-GIST-09-01 (Imatinib + LBH589) Dosage administration record 2009-011417-24
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1])
Continuing therapy
Item
OR Continuing
boolean
C1553904 (UMLS CUI [1])
Stop Date
Item
OR stop date
date
C0806020 (UMLS CUI [1])
Time of administration
Item
Time of administration
time
C1317775 (UMLS CUI [1])
Imatinib high dosage
Item
Imatinib
integer
C0935989 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,2])
Imatinib low dosage
Item
Imatinib
integer
C0935989 (UMLS CUI [1,1])
C0445550 (UMLS CUI [1,2])
C0445550 (UMLS CUI [1,2])
Dose reduction
Item
Dose reduction to
integer
C1707814 (UMLS CUI [1])
Dose reduction cause
Item
due to:
text
C0678226 (UMLS CUI [1,1])
C1707814 (UMLS CUI [1,2])
C1707814 (UMLS CUI [1,2])
Compliance
Item
Not taken due to:
text
C1321605 (UMLS CUI [1])
Item Group
Contribution of study medication
C1880177 (UMLS CUI-1)
C0304229 (UMLS CUI-2)
C0304229 (UMLS CUI-2)
Monday: date
Item
Monday: date
date
C0011008 (UMLS CUI [1,1])
C0585024 (UMLS CUI [1,2])
C0585024 (UMLS CUI [1,2])
Wednesday: date
Item
Wednesday: date
date
C0011008 (UMLS CUI [1,1])
C0585027 (UMLS CUI [1,2])
C0585027 (UMLS CUI [1,2])
Friday: date
Item
Friday: date
date
C0011008 (UMLS CUI [1,1])
C0585029 (UMLS CUI [1,2])
C0585029 (UMLS CUI [1,2])
CL Item
10 mg LBH589 (-1)
CL Item
20 mg LBH589 (0)
CL Item
30 mg LBH589 (1)
CL Item
40 mg LBH589 (2)
Item
Wednesday: cohort
integer
C0599755 (UMLS CUI [1,1])
C0585027 (UMLS CUI [1,2])
C0585027 (UMLS CUI [1,2])
CL Item
10 mg LBH589 (-1)
CL Item
20 mg LBH589 (0)
CL Item
30 mg LBH589 (1)
CL Item
40 mg LBH589 (2)
CL Item
10 mg LBH589 (-1)
CL Item
20 mg LBH589 (0)
CL Item
30 mg LBH589 (1)
CL Item
40 mg LBH589 (2)
Number high dose
Item
No. tabs 20 mg
integer
C0449788 (UMLS CUI [1,1])
C0444956 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,2])
Number low dose
Item
No. tabs 5 mg
integer
C0449788 (UMLS CUI [1,1])
C0445550 (UMLS CUI [1,2])
C0445550 (UMLS CUI [1,2])
Contribution: Dose reduction
Item
Dose reduction to:
integer
C1707814 (UMLS CUI [1,1])
C1880177 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,2])
Contribution: Dose reduction cause
Item
due to:
text
C1707814 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,3])
C0678226 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,3])
Contribution: compliance
Item
Not taken due to:
text
C1321605 (UMLS CUI [1,1])
C1880177 (UMLS CUI [1,2])
C1880177 (UMLS CUI [1,2])